ScholarIQanswers from OpenAlex
Lecanemab in Early Alzheimer’s Disease
PaperCitations, authors & open-access status
Lecanemab in Early Alzheimer’s Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lecanemab in Early Alzheimer’s Disease have?
ScholarIQcitation count
Lecanemab in Early Alzheimer’s Disease has 5,416 citations in the OpenAlex counts ScholarIQ stores.
When was Lecanemab in Early Alzheimer’s Disease published?
ScholarIQyear
Lecanemab in Early Alzheimer’s Disease has 2022 year in the ScholarIQ index.
What is the open-access status of Lecanemab in Early Alzheimer’s Disease?
ScholarIQoa status
Lecanemab in Early Alzheimer’s Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Lecanemab in Early Alzheimer’s Disease?
ScholarIQdoi
The DOI for Lecanemab in Early Alzheimer’s Disease is on the source record.
What is the PMID of Lecanemab in Early Alzheimer’s Disease?
ScholarIQpmid
The PMID for Lecanemab in Early Alzheimer’s Disease is on the source record.
What is the OpenAlex record for Lecanemab in Early Alzheimer’s Disease?
ScholarIQopenalex
The OpenAlex for Lecanemab in Early Alzheimer’s Disease is on the source record.